Federico Sandoval

2.8k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Federico Sandoval is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Federico Sandoval has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Federico Sandoval's work include Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Federico Sandoval is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Federico Sandoval collaborates with scholars based in France, United States and Switzerland. Federico Sandoval's co-authors include Éric Tartour, Magali Terme, Julien Taı̈eb, Elie Marcheteau, Alain Carpentier, Nadine Benhamouda, Olivier Dubreuil, Orianne Colussi, Simon Pernot and Hélène Péré and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Federico Sandoval

15 papers receiving 1.1k citations

Hit Papers

VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regul... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
    2012 522 citations Magali Terme, Simon Pernot et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Sandoval France 9 777 594 306 179 147 16 1.1k
Eric Groh United States 8 1.0k 1.3× 771 1.3× 384 1.3× 122 0.7× 91 0.6× 13 1.3k
Y Ino Japan 8 824 1.1× 584 1.0× 330 1.1× 189 1.1× 164 1.1× 8 1.2k
Inka Zoernig Germany 16 841 1.1× 625 1.1× 151 0.5× 141 0.8× 120 0.8× 24 1.1k
Sumita Trivedi United States 17 843 1.1× 583 1.0× 417 1.4× 289 1.6× 170 1.2× 33 1.5k
Elisa Rivas Spain 7 1.0k 1.3× 573 1.0× 455 1.5× 182 1.0× 255 1.7× 7 1.4k
Fernando Concha‐Benavente United States 19 1.1k 1.4× 688 1.2× 267 0.9× 281 1.6× 169 1.1× 31 1.4k
Laura Ridolfi Italy 20 1.2k 1.5× 877 1.5× 463 1.5× 309 1.7× 110 0.7× 67 1.6k
Tuba N. Gide Australia 12 1.3k 1.7× 985 1.7× 385 1.3× 240 1.3× 147 1.0× 22 1.7k
Mary Litzinger United States 13 721 0.9× 582 1.0× 454 1.5× 288 1.6× 189 1.3× 15 1.3k
Yasuko Tada Japan 6 877 1.1× 691 1.2× 167 0.5× 270 1.5× 103 0.7× 8 1.2k

Countries citing papers authored by Federico Sandoval

Since Specialization
Citations

This map shows the geographic impact of Federico Sandoval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Sandoval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Sandoval more than expected).

Fields of papers citing papers by Federico Sandoval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Sandoval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Sandoval. The network helps show where Federico Sandoval may publish in the future.

Co-authorship network of co-authors of Federico Sandoval

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Sandoval. A scholar is included among the top collaborators of Federico Sandoval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Sandoval. Federico Sandoval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Costa-Nunes, Carla, Amélie Cachot, Sara Bobisse, et al.. (2019). High-throughput Screening of Human Tumor Antigen–specific CD4 T Cells, Including Neoantigen-reactive T Cells. Clinical Cancer Research. 25(14). 4320–4331. 13 indexed citations
2.
3.
Melero, Ignacio, Neil H. Segal, Willeke Ros, et al.. (2017). Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors. Annals of Oncology. 28. v28–v28. 2 indexed citations
4.
Melero, Ignacio, Neil H. Segal, Willeke Ros, et al.. (2017). Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA CD3 TCB) for the treatment of CEA-expressing solid tumors.. Journal of Clinical Oncology. 35(15_suppl). 2549–2549. 1 indexed citations
5.
6.
Nizard, Mevyn, Federico Sandoval, Cécile Badoual, et al.. (2013). Immunotherapy of HPV-associated head and neck cancer. OncoImmunology. 2(6). e24534–e24534. 14 indexed citations
7.
Faye, N., Olivier Clémеnt, Daniel Balvay, et al.. (2013). Multiparametric optical and MR imaging demonstrate inhibition of tumor angiogenesis natural history by mural cell therapy. Magnetic Resonance in Medicine. 72(3). 841–849. 1 indexed citations
8.
Dosset, Magalie, Yann Godet, Charline Vauchy, et al.. (2012). Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor. Clinical Cancer Research. 18(22). 6284–6295. 47 indexed citations
9.
Terme, Magali, Simon Pernot, Elie Marcheteau, et al.. (2012). VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer. Cancer Research. 73(2). 539–549. 522 indexed citations breakdown →
10.
Péré, Hélène, Corinne Tanchot, Jagadeesh Bayry, et al.. (2012). Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer. OncoImmunology. 1(3). 326–333. 87 indexed citations
11.
Terme, Magali, Simon Pernot, Elie Marcheteau, et al.. (2012). VEGF-a-induced Treg Proliferation, A Novel Mechanism of Tumor Immune Escape in Colorectal Cancer: Effects of Anti-VEGF/VEGFR Therapies. Annals of Oncology. 23. ix75–ix75. 1 indexed citations
12.
Tartour, Éric, Hélène Péré, Bernard Maillère, et al.. (2011). Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer and Metastasis Reviews. 30(1). 83–95. 249 indexed citations
13.
Péré, Hélène, Jagadeesh Bayry, Françoise Quintin‐Colonna, et al.. (2011). Abstract 752: A CCR4 antagonist combined with protein-or DNA-based vaccines efficiently breaks tolerance and elicits CD8+T cells directed against self and viral associated tumor antigens. Cancer Research. 71(8_Supplement). 752–752.
14.
Tartour, Éric, Federico Sandoval, Jean‐Yves Bonnefoy, & Wolf H. Fridman. (2011). Immunothérapie des cancers. médecine/sciences. 27(10). 833–841. 8 indexed citations
15.
Badoual, Cécile, Federico Sandoval, Hélène Péré, et al.. (2010). Better understanding tumor–host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head & Neck. 32(7). 946–958. 49 indexed citations
16.
Rosa, José M. de la, et al.. (2010). Design of a 1-V 90-nm CMOS folded cascode LNA for multi-standard applications. DIGITAL.CSIC (Spanish National Research Council (CSIC)). 185–188. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Groh Breakdown of academic impact, for papers by Y Ino Breakdown of academic impact, for papers by Inka Zoernig Breakdown of academic impact, for papers by Sumita Trivedi Breakdown of academic impact, for papers by Elisa Rivas Breakdown of academic impact, for papers by Fernando Concha‐Benavente Breakdown of academic impact, for papers by Laura Ridolfi Breakdown of academic impact, for papers by Tuba N. Gide Breakdown of academic impact, for papers by Mary Litzinger Breakdown of academic impact, for papers by Yasuko Tada
Rankless by CCL
2026